Literature DB >> 33554456

Costs of the COVID-19 pandemic associated with obesity in Europe: A health-care cost model.

Sebastien Czernichow1,2,3, Stephen C Bain4, Matthew Capehorn5, Mette Bøgelund6, Maria Elmegaard Madsen6, Cecilie Yssing6, Annabell Cajus McMillan6, Ana-Paula Cancino7, Ulrik Haagen Panton7.   

Abstract

Excess weight is associated with severe outcomes of coronavirus disease 2019 (COVID-19). We aimed to estimate the total secondary care costs by body mass index (BMI, kg/m2 ) category when hospitalized due to COVID-19 in Europe during the first wave of the pandemic from January to June 2020. Building a health-care cost model, this study aimed to estimate the total costs of COVID-19. Information on risk of hospitalization, admission to intensive care unit (ICU) and risk of ventilation were based on published data. Average cost per patient and in total were calculated based on risks of admission to ICU, risk of invasive mechanical ventilation and length of hospital stay when hospitalized and published costs associated with hospitalization. The total direct costs of secondary care during the first wave of COVID-19 in Europe were estimated at EUR 13.9 billon, whereof 76% accounted for treating people with overweight and obesity. The average cost per hospital admission increased with BMI, from EUR 15831 for BMI <25 kg/m2 to EUR 30982 for BMI ≥40 kg/m2 . This study reveals that excess weight contributes disproportionally to the costs of COVID-19. This might reflect that overweight and obesity caused the COVID-19 pandemic to result in more severe outcomes for citizens and higher secondary care costs throughout Europe.
© 2021 The Authors. Clinical Obesity published by John Wiley & Sons Ltd on behalf of World Obesity Federation.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; health economics; obesity; pandemic

Mesh:

Year:  2021        PMID: 33554456     DOI: 10.1111/cob.12442

Source DB:  PubMed          Journal:  Clin Obes        ISSN: 1758-8103


  7 in total

1.  Obesity: Policy and Practice Recommendations for High-Risk Populations Influenced by the COVID-19 Pandemic.

Authors:  Kathryn N Robinson; Deborah A Saber
Journal:  mSystems       Date:  2022-05-31       Impact factor: 7.324

2.  Why are COVID-19 effects less severe in Sub-Saharan Africa? Moving more and sitting less may be a primary reason.

Authors:  Lucy-Joy Wachira; Ross Arena; James F Sallis; Estelle V Lambert; Otieno Martin Ong'wen; Deepika R Laddu; Vincent Onywera; Adewale L Oyeyemi
Journal:  Prog Cardiovasc Dis       Date:  2022-04-27       Impact factor: 11.278

Review 3.  Excess Body Mass-A Factor Leading to the Deterioration of COVID-19 and Its Complications-A Narrative Review.

Authors:  Weronika Gryczyńska; Nikita Litvinov; Bezawit Bitew; Zuzanna Bartosz; Weronika Kośmider; Paweł Bogdański; Damian Skrypnik
Journal:  Viruses       Date:  2021-12-03       Impact factor: 5.818

4.  The Effect of Pandemic Movement Restriction Policies on Children's Physical Fitness, Activity, Screen Time, and Sleep.

Authors:  Shawnda A Morrison; Kaja Meh; Vedrana Sember; Gregor Starc; Gregor Jurak
Journal:  Front Public Health       Date:  2021-12-06

5.  Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England.

Authors:  Adrian Kilcoyne; Edward Jordan; Kimberly Thomas; Alicia N Pepper; Allen Zhou; Dale Chappell; Miyuru Amarapala; Rachel-Karson Thériault; Melissa Thompson
Journal:  Clinicoecon Outcomes Res       Date:  2022-04-14

6.  Predicting the cost of COVID-19 treatment and its drivers in Indonesia: analysis of claims data of COVID-19 in 2020-2021.

Authors:  Ryan R Nugraha; Mutia A Pratiwi; Ruli Endepe Al-Faizin; Ardian Budi Permana; Ery Setiawan; Yuli Farianty; Kalsum Komaryani; Hasbullah Thabrany
Journal:  Health Econ Rev       Date:  2022-08-31

7.  Association between COVID-19 morbidity, mortality, and gross domestic product, overweight/ obesity, non-communicable diseases, vaccination rate: A cross-sectional study.

Authors:  Kuat Oshakbayev; Zulfiya Zhankalova; Meruyert Gazaliyeva; Khalit Mustafin; Gulnara Bedelbayeva; Bibazhar Dukenbayeva; Nurzhan Otarbayev; Attila Tordai
Journal:  J Infect Public Health       Date:  2022-01-14       Impact factor: 3.718

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.